Inhibrx Biosciences, Inc. (INBX) earnings
INBX earnings moved a median of -0.46% by the close. Quarterly and annual INBX reports and results, each read against the price at its own news timestamp. Back to the INBX overview →
20 measured INBX earnings events.
Where these INBX earnings landedvs 20 measured INBX earnings reactions
| Middle 50% of INBX earnings reactions | -3.74% to +3.38% |
|---|---|
| Median reaction (to close) | -0.46% |
| Measured reactions | 20 |
Point-in-time · zero look-ahead
Half of the 20 INBX earnings events with a measured close landed between -3.74% and +3.38%; 45% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Inhibrx Biosciences, For: Jun 30 | SEC filing · Form 10-Q | +3.38% | -3.74% | |
| Inhibrx Reports Second Quarter 2026 Financial Results | Press release | +3.38% | -3.74% | |
| Form 10-Q Inhibrx Biosciences, For: Mar 31 | SEC filing · Form 10-Q | -3.70% | -8.38% | |
| Inhibrx Reports First Quarter 2026 Financial Results | Press release | -3.70% | -8.38% | |
| Form 10-K Inhibrx Biosciences, For: Dec 31 | SEC filing · Form 10-K | -1.21% | -4.65% | |
| Form 10-Q Inhibrx Biosciences, For: Sep 30 | SEC filing · Form 10-Q | +1.76% | +8.55% | |
| Inhibrx Reports Third Quarter 2025 Financial Results | Press release | +1.76% | +8.55% | |
| Form 10-Q Inhibrx Biosciences, For: Jun 30 | SEC filing · Form 10-Q | -0.48% | -0.46% | |
| Inhibrx Reports Second Quarter 2025 Financial Results | Press release | -0.48% | -0.46% | |
| Form 10-Q Inhibrx Biosciences, For: Mar 31 | SEC filing · Form 10-Q | +2.33% | +9.57% | |
| Inhibrx Reports First Quarter 2025 Financial Results | Press release | +2.33% | +9.57% | |
| Form 10-K Inhibrx Biosciences, For: Dec 31 | SEC filing · Form 10-K | -0.96% | +3.47% | |
| Form 10-Q Inhibrx Biosciences, For: Sep 30 | SEC filing · Form 10-Q | +3.05% | -3.49% | |
| Inhibrx Biosciences Reports Third Quarter 2024 Financial Results | Press release | +3.05% | -3.49% | |
| Form 10-Q Inhibrx Biosciences, For: Jun 30 | SEC filing · Form 10-Q | -0.22% | +0.18% | |
| Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights | Press release | -0.22% | +0.18% | |
| Form 10-Q Inhibrx, Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.02% | -0.90% | |
| Form 10-K Inhibrx, Inc. For: Dec 31 | SEC filing · Form 10-K | -0.46% | -5.66% | |
| Form 10-Q Inhibrx, Inc. For: Sep 30 | SEC filing · Form 10-Q | -1.95% | +3.35% | |
| Inhibrx Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights | Press release | -1.95% | +3.35% |
Keep exploring
More INBX: analyst actions → · SEC filings → · INBX overview →